Literature DB >> 21677650

The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice.

Michael Lukas1, Iulia Toth, Stefan O Reber, David A Slattery, Alexa H Veenema, Inga D Neumann.   

Abstract

Social avoidance and social phobia are core symptoms of various psychopathologies but their underlying etiology remains poorly understood. Therefore, this study aims to reveal pro-social effects of the neuropeptide oxytocin (OT), under both basal and stress-induced social avoidance conditions in rodents using a social preference paradigm. We initially show that intracerebroventricular (i.c.v.) application of an OT receptor antagonist (OTR-A) in naïve male rats (0.75 μg/5 μl), or mice (20 μg/2 μl), reduced social exploration of a novel con-specific indicative of attenuated social preference. Previous exposure of male rats to a single social defeat resulted in loss of their social preference and social avoidance, which could be restored by i.c.v. infusion of synthetic OT (0.1 μg/5 μl) 20 min before the social preference test. Although the amygdala has been implicated in both social and OT-mediated actions, bilateral OTR-A (0.1 μg/1 μl) or OT (0.01 μg/1 μl) administration into various subnuclei of the amygdala did not affect basal or stress-induced social preference behavior, respectively. Finally, we demonstrate the social specificity of these OT-mediated effects by showing that neither an arginine vasopressin V1a receptor antagonist (0.75 μg/5 μl, i.c.v.) nor the anxiogenic drug pentylenetetrazol (15 mg/kg, i.p.) altered social preference, with OTR-A not affecting non-social anxiety on the elevated plus-maze. Overall, the data indicate that the basal activity of the endogenous brain OT system is sufficient to promote natural occurring social preference in rodents while synthetic OT shows potential to reverse stress-induced social avoidance and might thus be of use for treating social phobia and social dysfunction in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677650      PMCID: PMC3176581          DOI: 10.1038/npp.2011.95

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  75 in total

Review 1.  Dendritic peptide release and peptide-dependent behaviours.

Authors:  Mike Ludwig; Gareth Leng
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

2.  Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain.

Authors:  P Popik; J M van Ree
Journal:  Eur Neuropsychopharmacol       Date:  1991-12       Impact factor: 4.600

3.  A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats.

Authors:  K Ebner; C T Wotjak; R Landgraf; M Engelmann
Journal:  Brain Res       Date:  2000-07-28       Impact factor: 3.252

4.  A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").

Authors:  M R Thompson; P D Callaghan; G E Hunt; J L Cornish; I S McGregor
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

5.  Oxytocin and vasopressin in the medial amygdala differentially modulate approach and avoidance behavior toward illness-related social odor.

Authors:  H Arakawa; K Arakawa; T Deak
Journal:  Neuroscience       Date:  2010-10-08       Impact factor: 3.590

Review 6.  The involvement of the vasopressin system in stress-related disorders.

Authors:  Rainer Landgraf
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-04       Impact factor: 4.388

7.  Polymodal dose-response curve for oxytocin in the social recognition test.

Authors:  A Benelli; A Bertolini; R Poggioli; B Menozzi; R Basaglia; R Arletti
Journal:  Neuropeptides       Date:  1995-04       Impact factor: 3.286

8.  Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Authors:  Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

9.  Mesotocin and nonapeptide receptors promote estrildid flocking behavior.

Authors:  James L Goodson; Sara E Schrock; James D Klatt; David Kabelik; Marcy A Kingsbury
Journal:  Science       Date:  2009-08-14       Impact factor: 47.728

10.  Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography.

Authors:  E Tribollet; C Barberis; S Jard; M Dubois-Dauphin; J J Dreifuss
Journal:  Brain Res       Date:  1988-02-23       Impact factor: 3.252

View more
  120 in total

1.  Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.

Authors:  Erwin H van den Burg; Benjamin Jurek; Inga D Neumann; Julia Winter; Magdalena Meyer; Ilona Berger; Melanie Royer; Marta Bianchi; Kerstin Kuffner; Sebastian Peters; Simone Stang; Dominik Langgartner; Finn Hartmann; Anna K Schmidtner; Stefan O Reber; Oliver J Bosch; Anna Bludau; David A Slattery
Journal:  Mol Psychiatry       Date:  2021-05-25       Impact factor: 15.992

Review 2.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

3.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

4.  Can understanding social preferences in rodents lead to novel pharmacotherapies for social anxiety and avoidance in psychiatric disorders?

Authors:  Larry J Young
Journal:  Neuropsychopharmacology       Date:  2011-10       Impact factor: 7.853

5.  Neural Circuits Underlying Rodent Sociality: A Comparative Approach.

Authors:  Nicole S Lee; Annaliese K Beery
Journal:  Curr Top Behav Neurosci       Date:  2019

6.  WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.

Authors:  Callum Hicks; Linnet Ramos; Tristan A Reekie; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

7.  Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups.

Authors:  Yoav Litvin; Cortney A Turner; Mariel B Rios; Pamela M Maras; Sraboni Chaudhury; Miriam R Baker; Peter Blandino; Stanley J Watson; Huda Akil; Bruce McEwen
Journal:  Horm Behav       Date:  2016-09-28       Impact factor: 3.587

8.  Oxytocin and vasopressin modulation of social anxiety following adolescent intermittent ethanol exposure.

Authors:  Carol A Dannenhoffer; Esther U Kim; Jessica Saalfield; David F Werner; Elena I Varlinskaya; Linda P Spear
Journal:  Psychopharmacology (Berl)       Date:  2018-08-23       Impact factor: 4.530

9.  Sociality and oxytocin and vasopressin in the brain of male and female dominant and subordinate mandarin voles.

Authors:  Xufeng Qiao; Yating Yan; Ruiyong Wu; Fadao Tai; Ping Hao; Yan Cao; Jianli Wang
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2013-12-01       Impact factor: 1.836

10.  Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum.

Authors:  Iulia Zoicas; David A Slattery; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2014-06-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.